Skip to content
Home
About Us
Main Business Clinical
Main Business Clinical
Clinical process
Information
Newsletter
Clinical Trial Information
Korea Clinical Trial Status
Pharmaceutical Approval Status in Korea
Medical Device Approval Status in Korea
English
English
한국어
Quotation Request
Connecting people, advancing clinical value
Home
About Us
Main Business
Main Business
Clinical Trial Process
Information
Notice
Newsletter
Clinical Trial Information
FDA/EMA Global Submission Strategies
Regulatory & Guideline Updates
Clinical Trend Insights
CRO Knowledge
Korea Clinical Trial Status
Pharmaceutical Approval Status in Korea
Medical Device Approval Status in Korea
English
English
한국어
Quotation Request
Connecting people, advancing clinical value
Menu
Clinical Trend Insights
Connecting people, advancing clinical value
Clinical Trials: Global CRO Playbook for 2026
2026/03/04
2025 Top 10 Drug Sales Compared: What the U.S., China, and Korea Reveal About Market Structure—and What to Expect in 2026
2026/02/25
2025 IND Trends and 2026 Clinical Trials Outlook
2026/02/18
Clinical Trials in the AI Era: How Smart Systems and CRO Upheaval Are Redefining Drug Development
2026/02/11
AI is Transforming Non Clinical Trials through Innovation
2026/02/04
AI-Enabled Biopharma in 2026: Sponsor & CRO Playbook for Discovery, Evidence Generation, and Responsible AI
2026/01/28
Molecular Glue Degraders in 2026: Clinical Trials Surge, China-Korea Strategy & Korea’s Precision Oncology Edge
2026/01/21
Designing Radiopharmaceutical Theranostic Clinical Trials in South Korea
2026/01/14
Korea’s 2026 Cancer Clinical Trials Outlook: Data Trends and Planning Insights
2025/12/31
1
2
When selecting a CRO partner, which factor matters most to you?
Referral / a CRO I already know
Proven experience in our therapeutic area
Budget transparency
Speed and operational responsiveness (fast start-up, quick issue resolution)
Other (please specify)
Submit
X